Cambridge Investment Research Advisors’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
12,142
+2,333
+24% +$199K ﹤0.01% 2271
2026
Q1
$879K Buy
9,809
+6,923
+240% +$665K ﹤0.01% 2287
2025
Q4
$268K Buy
2,886
+274
+10% +$29.8K ﹤0.01% 3311
2025
Q3
$325K Buy
2,612
+110
+4% +$14K ﹤0.01% 3052
2025
Q2
$329K Buy
2,502
+5
+0.2% +$566 ﹤0.01% 2899
2025
Q1
$262K Sell
2,497
-94
-4% -$9.84K ﹤0.01% 2985
2024
Q4
$281K Sell
2,591
-157
-6% -$17.5K ﹤0.01% 2890
2024
Q3
$294K Buy
2,748
+165
+6% +$16.7K ﹤0.01% 2845
2024
Q2
$256K Buy
+2,583
New +$260K ﹤0.01% 2833

Other funds holding ITRI

Cambridge Investment Research Advisors's ITRI Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Itron (ITRI) stake by 24% in Q2 2026, buying an estimated $199K and bringing the position to 12,142 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2271.

Cambridge Investment Research Advisors first reported a position in ITRI in Q2 2024 and has held it in 9 quarters since. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Cambridge Investment Research Advisors held 12,142 shares of Itron worth $1.05M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 2,333 Itron shares in Q2 2026, an estimated $199K.
  • Itron made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2271 holding.
  • Cambridge Investment Research Advisors first reported a position in Itron in Q2 2024 and has held it in 9 quarters since.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.